Contracts › 75A50326F80006
75A50326F80006: Atropine 0.4MGML X 20ML Soln. for Inj., Multi-Dose Vials 8MG and Midazolam Soln. for Inj., 5MG/Ml, Multi-Dose Vials Eo 14398
Awarded to Fresenius Kabi, Llc by Office of Assistant Secretary for Preparedness and Response.
$7.9Mobligated
$7.9Mpotential value
29 July 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50326F80006 |
|---|---|
| Vehicle | 36F79725D0145 |
| Awardee | Fresenius Kabi, Llc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | ASPR/ORM-SNS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | IL |
| Offers received | 2 |
| Period of performance | 30 July 2026 to 29 July 2027 |
| Potential end | 29 July 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 14 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record